Aslani, Baby Girl -.
HRN: 22-76-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
OXACILLIN 500MG (VIAL)
04/23/2024
04/30/2024
IV
250mg
Q6H
Staphylococcal Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: No